Showing results (131-140 of 410) with videos related to
Sort By:
Pageof 41
Cancer Immunology, Immunotherapy : CII|January 22, 2021
Cytokine changes during immune-related adverse events and corticosteroid treatment in melanoma patients receiving immune checkpoint inhibitorsKevin Tyan, Joanna Baginska, Martha Brainard, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 2009
Guidelines for the evaluation of immune therapy activity in solid tumors: immune-related response criteriaJedd D Wolchok, Axel Hoos, Steven O'Day, et al.Journal for Immunotherapy of Cancer|August 18, 2016
Cardiotoxicity associated with CTLA4 and PD1 blocking immunotherapyLucie Heinzerling, Patrick A Ott, F Stephen Hodi, et al.Frontiers in Oncology|June 26, 2023
A phase Ib trial of combined PKC and MEK inhibition with sotrastaurin and binimetinib in patients with metastatic uveal melanomaSebastian Bauer, James Larkin, F Stephen Hodi, et al.The American Journal of Surgical Pathology|January 12, 2016
Expression of Programmed Cell Death 1 Ligands (PD-L1 and PD-L2) in Histiocytic and Dendritic Cell DisordersJie Xu, Heather H Sun, Christopher D M Fletcher, et al.Journal for Immunotherapy of Cancer|February 8, 2022
Soluble PD-L1 as an early marker of progressive disease on nivolumabKathleen M Mahoney, Petra Ross-Macdonald, Long Yuan, et al.Cancer Imaging : the Official Publication of the International Cancer Imaging Society|January 23, 2015
Metabolic response by FDG-PET to imatinib correlates with exon 11 KIT mutation and predicts outcome in patients with mucosal melanomaKatherine Zukotynski, Jeffrey T Yap, Anita Giobbie-Hurder, et al.Melanoma Research|February 24, 2021
The efficacy of immunotherapy for in-transit metastases of melanoma: an analysis of randomized controlled trialsRoger Olofsson Bagge, Lars Ny, Paolo A Ascierto, et al.NPJ Precision Oncology|June 30, 2021
Bevacizumab improves tumor infiltration of mature dendritic cells and effector T-cells in triple-negative breast cancer patientsYves Boucher, Ashwin S Kumar, Jessica M Posada, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2008
Imatinib targeting of KIT-mutant oncoprotein in melanomaXiaofeng Jiang, Jun Zhou, Noah K Yuen, et al.Pageof 41